Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-23

Clinical Trial Update: Different Safety Profile of Risperidone and Paliperidone Extended-release [Phase 4]

View source ↗

Summary

Phase 4 trial comparing safety profiles of risperidone and paliperidone extended-release in schizophrenia; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVEGA (PALIPERIDONE)
  • Risperdal (risperidone)

Snippet

Sponsor: Chonbuk National University Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2012-10-23